Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.

Ahn JS, Eom CS, Jeon CY, Park SM.

World J Gastroenterol. 2013 Apr 28;19(16):2560-8. doi: 10.3748/wjg.v19.i16.2560. Review.

2.

Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.

Tamim H, Duranceau A, Chen LQ, Lelorier J.

Drug Saf. 2008;31(8):675-84.

PMID:
18636786
3.

Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.

Eom CS, Park SM, Myung SK, Yun JM, Ahn JS.

Ann Fam Med. 2011 May-Jun;9(3):257-67. doi: 10.1370/afm.1243.

4.

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.

Yu EW, Bauer SR, Bain PA, Bauer DC.

Am J Med. 2011 Jun;124(6):519-26. doi: 10.1016/j.amjmed.2011.01.007.

5.

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis.

Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS.

CMAJ. 2011 Feb 22;183(3):310-9. doi: 10.1503/cmaj.092129. Epub 2010 Dec 20. Review.

6.

Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis.

Tran-Duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CD.

Clin Gastroenterol Hepatol. 2016 Dec;14(12):1706-1719.e5. doi: 10.1016/j.cgh.2016.05.018. Epub 2016 May 20. Review.

PMID:
27211501
7.

Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysis.

Zhang YS, Li Q, He BS, Liu R, Li ZJ.

World J Gastroenterol. 2015 May 28;21(20):6341-51. doi: 10.3748/wjg.v21.i20.6341. Review.

8.

Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.

Tariq R, Singh S, Gupta A, Pardi DS, Khanna S.

JAMA Intern Med. 2017 Jun 1;177(6):784-791. doi: 10.1001/jamainternmed.2017.0212. Review.

PMID:
28346595
9.

Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.

Deshpande A, Pasupuleti V, Thota P, Pant C, Mapara S, Hassan S, Rolston DD, Sferra TJ, Hernandez AV.

J Gastroenterol Hepatol. 2013 Feb;28(2):235-42. doi: 10.1111/jgh.12065. Review.

PMID:
23190338
10.

Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.

Poulsen AH, Christensen S, McLaughlin JK, Thomsen RW, Sørensen HT, Olsen JH, Friis S.

Br J Cancer. 2009 May 5;100(9):1503-7. doi: 10.1038/sj.bjc.6605024. Epub 2009 Apr 7.

11.

Risk of Stroke-Associated Pneumonia With Acid-Suppressive Drugs: A Population-Based Cohort Study.

Ho SW, Hsieh MJ, Yang SF, Yeh YT, Wang YH, Yeh CB.

Medicine (Baltimore). 2015 Jul;94(29):e1227. doi: 10.1097/MD.0000000000001227.

12.

Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.

Corley DA, Kubo A, Zhao W, Quesenberry C.

Gastroenterology. 2010 Jul;139(1):93-101. doi: 10.1053/j.gastro.2010.03.055. Epub 2010 Mar 27.

13.

Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.

Song H, Zhu J, Lu D.

Cochrane Database Syst Rev. 2014 Dec 2;(12):CD010623. doi: 10.1002/14651858.CD010623.pub2. Review.

PMID:
25464111
14.

Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.

Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK.

Am J Gastroenterol. 2012 Jul;107(7):1011-9. doi: 10.1038/ajg.2012.108. Epub 2012 Apr 24. Erratum in: Am J Gastroenterol. 2014 Jan;109(1):144.

PMID:
22525304
15.

Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.

Wijarnpreecha K, Thongprayoon C, Chesdachai S, Panjawatanana P, Ungprasert P, Cheungpasitporn W.

Dig Dis Sci. 2017 Oct;62(10):2821-2827. doi: 10.1007/s10620-017-4725-5. Epub 2017 Aug 23. Review.

PMID:
28836158
16.

Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.

Bajaj JS, Ratliff SM, Heuman DM, Lapane KL.

Aliment Pharmacol Ther. 2012 Nov;36(9):866-74.

17.

Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia.

Herzig SJ, Doughty C, Lahoti S, Marchina S, Sanan N, Feng W, Kumar S.

Ann Neurol. 2014 Nov;76(5):712-8. doi: 10.1002/ana.24262. Epub 2014 Sep 17.

18.

Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.

Myles PR, Hubbard RB, McKeever TM, Pogson Z, Smith CJ, Gibson JE.

Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):269-75. doi: 10.1002/pds.1715.

PMID:
19235776
19.

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.

Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB.

JAMA. 2004 Oct 27;292(16):1955-60.

PMID:
15507580
20.

Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.

García Rodríguez LA, Lagergren J, Lindblad M.

Gut. 2006 Nov;55(11):1538-44. Epub 2006 Jun 19.

Supplemental Content

Support Center